Children’s National Hospital experts will attend the 54th Annual Child Neurology Society Annual Meeting in Charlotte, North Carolina. The post Children’s National experts at the Child Neurology Society 2025 Annual Meeting appeared first on Innovation District.| Innovation District
Fragile X research is at a turning point. Two late-stage clinical trials, zatolmilast (EXPERIENCE) and ZYN002 (RECONNECT), could soon deliver the first approved treatments. FRAXA is also funding innovative approaches like ASO therapy and CRISPR-based gene reactivation to target the root cause of Fragile X. The post Fragile X Research Update: A Turning Point for Treatments and Curative Approaches appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome